Recruitment

Recruitment Status
Active, not recruiting
Estimated Enrollment
30

Summary

Conditions
  • Melanoma
  • Neuroblastoma
  • Sarcoma
Type
Interventional
Phase
Not Applicable
Design
Allocation: N/AIntervention Model: Single Group AssignmentMasking: None (Open Label)Primary Purpose: Diagnostic

Participation Requirements

Age
Between 3 years and 90 years
Gender
Both males and females

Description

Not Provided

Not Provided

Tracking Information

NCT #
NCT02307630
Collaborators
Y-mAbs Therapeutics
Investigators
Principal Investigator: Shakeel Modak, MD Memorial Sloan Kettering Cancer Center